Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis

Thorax

Volumn 54, Issue 11, 1999, Pages 1015-1020

  Ashitani, Jun ichi ^a   Mukae, Hiroshi ^a   Taniguchi, Haruko ^a   Ihi, Toshihiko ^a   Kadota, Jun ichi ^b   Kohno, Shigeru ^b   Matsukura, Shigeru ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bronchoalveolar lavage fluid; Granulocyte colony stimulating factor; Idiopathic pulmonary fibrosis

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; HUMAN; LUNG LAVAGE; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0032699396     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.11.1015     Document Type: Article

References (28)

1. Crystal RG, Gadek JE, Ferrans JD, et al. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med 1981;70:542-68.
2. Haellgren R, Bjermer L, Lundgren R, et al. The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function. Am Rev Respir Dis 1989;139:373-7.
3. Gadek JE, Hunninghake GW, Zimmermann RL, et al. Regulation of the release of alveolar macrophage-derived neutrophil chemotactic factor. Am Rev Respir Dis 1980;121:723-33.
4. Wells AU, Hansell DM, Haslam PL, et al. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis. Am J Respir Crit Care Med 1998;157:1474-82.
5. Rudd RM, Haslam PL, Turner-Warwick M. Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis 1981;124:1-8.
6. Wells AU, Hansell DM, Rubens MB, et al. Fibrosing alveolitis in systemic sclerosis: bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med 1994;150:462-8.
7. Ozaki T, Hayashi H, Tani K, et al. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992;145:85-91.
8. Car BD, Meloni F, Luisetti M, et al. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:655-9.
9. Xaubet A, Agusti C, Luburich P, et al. Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis. Respir Med 1998;92:338-44.
10. Carrè PC, Mortenson RL, King TE Jr, et al. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis. J Clin Invest 1991;88:1802-10.
11. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony stimulating factors. Blood 1986;67:257-67.
12. Platzer E, Welte K, Gabrilove JL, et al. Biological activities of a human pluripotent hemopoietic colony-stimulating factor on normal and leukemic cells. J Exp Med 1985;162:1788-801.
13. Cohen AM, Zsebo KM, Inoue H, et al. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 1987;84:2484-8.
14. Souza LM, Boone TC, Gabrilove J, et al. Recombinant human granulocyte-colony stimulating factor: effects on normal and leukemic myeloid cells. Science 1986;232:61-5.
15. Welte K, Bonilla MA, Gillio AP, et al. Recombinant human granulocyte-colony stimulating factor: effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 1987;165:941-9.
16. Gabrilove JL, Jakubowski A, Scher H, et al. Effects of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-22.
17. Wang JM, Chen ZG, Colella S, et al. Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood 1988;72:1456-60.
18. Yong KL, Linch DC. Differential effects of granulocyte- and granulocyte-macrophage colony-stimulating factors (G- and GM-CSF) on neutrophil adhesion in vitro and in vivo. Eur J Haematol 1992;49:251-9.
19. Klech H, Pohl W. Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Respir J 1989;2:561-85.
20. Falk W, Goodwin RH, Leonard EJ. A 48-well microchemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol 1980;33:239-47.
21. Ferrante A, Thong YH. A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the hypaque-ficoll technique. J Immunol Methods 1978;24:389-93.
22. Kamachi S, Matsubara K, Kobayashi T, et al. Preparation and characteristics of anti-recombinant human G-CSF (rGCSF) antibodies. Jpn Pharmacol Ther 1990;18:S2221-6.
23. Oishi K, Sonoda F, Kobayashi S, et al. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect Immun 1994;62:4145-52.
24. Miller EJ, Cohen AB, Nagao S, et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992;146:427-32.
25. Ozaki T, Hayashi H, Tani K, et al. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992;145:85-91.
26. Car BD, Meloni F, Luisetti M, et al. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:655-9.
27. Tazi A, Nioche S, Chastre J, et al. Spontaneous release of granulocyte colony-stimulating factor (G-CSF) by alveolar macrophages in the course of bacterial pneumonia and sarcoidosis: endotoxin-dependent and endotoxin-independent G-CSF release by cells recovered by bronchoalveolar lavage. Am J Respir Cell Mol Biol 1991;4:140-7.
28. Watari K, Asano S, Shirafuji N, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as established by enzyme immunoassay. Blood 1989;73:117-22.